FDA Adverse Event Injury Summary report: N

CYPHER SIROLIMUS-ELUTING CORONARY STENT

MDR report key: 1161265 · Received September 12, 2008

Report

Report Number
9616099-2008-02225
Event Type
Injury
Date Received
September 12, 2008
Date of Event
January 22, 2008
Report Date
August 21, 2008
Manufacturer
CORDIS DE MEXICO
Product Code
NIQ
PMA / PMN Number
NA
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SF
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE IS DISTRIBUTED OUTSIDE THE UNITED STATES; HOWEVER IT IS SIMILAR TO THE UNITED STATES PRODUCT. THIS DEVICE IS ONE OF THREE PRODUCTS ASSOCIATED WITH THIS EVENT. PLEASE REFER TO MFR REPORT# 9610978-2008-00231, 9616099-2008-00224. THE PRODUCT REMAINED IMPLANTED IN THE PT, AND IS NOT AVAILABLE FOR ANALYSIS. ADDITIONAL INFO WILL BE SUBMITTED WITHIN THIRTY DAYS UPON RECEIPT.

Description of Event or Problem · 1

THE NOTIFICATION RECEIVED FOR THE STUDY INDICATED THAT A MALE UNDERWENT IMPLANTATION OF A 3.00 X 28MM CYPHER SELECT PLUS STENT IN THE PROXIMAL LEFT ANTERIOR DESCENDING ARTERY (LAD) AND A 3.00 X 18MM CYPHER SELECT PLUS STENT IN THE PROXIMAL CIRCUMFLEX. THE LAD WAS AN IN-STENT RESTENOSIS OF A PREVIOUSLY IMPLANTED PALMAZ SCHATZ STENT. AT THE SIX MONTH FOLLOW-UP IN LATE 2007, THE PT HAD ANGINA. IN EARLY 2008, THE PT COMPLAINED OF ANGINA, AN ANGIOGRAM SHOWED THAT THE STENTS IN THE CIRCUMFLEX AND LEFT ANTERIOR DESCENDING ARTERY (LAD) WERE STILL WIDELY PATENT BUT A NEW DISEASE HAD DEVELOPED, NAMELY A CRITICAL STENOSIS IN THE DISTAL PART OF THE MAIN STEM. THE PT WAS ADVISED TO HAVE CABG. THE EVENT WAS GRADED AS UNRELATED TO THE IMPLANTED CYPHER STENTS. THE STENOSIS IN THE DISTAL LEFT MAIN WAS WITHIN 4-5MM OF THE IMPLANTED CYPHER STENTS. THIS WILL BE CAPTURED AS PERI-STENT RESTENOSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CYPHER SIROLIMUS-ELUTING CORONARY STENT DRUG-ELUTING STENT (NIQ) NIQ CORDIS DE MEXICO NA 13191787

Patients

Seq Age Sex Outcome Treatment
1 61 YR Hospitalization| R CLOPIDOGREL